Company Description
McKesson Corporation provides healthcare services in the United States and internationally.
It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies.
The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services.
The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies.
The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers.
McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
| Country | United States |
| Founded | 1833 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 51,000 |
| CEO | Brian Tyler |
Contact Details
Address: 6555 State Highway 161 Irving, Texas 75039 United States | |
| Phone | 972 446 4800 |
| Website | mckesson.com |
Stock Details
| Ticker Symbol | MCK |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0000927653 |
| CUSIP Number | 58155Q103 |
| ISIN Number | US58155Q1031 |
| Employer ID | 94-3207296 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Kirk Kaminsky | President of The US Pharmaceutical and Specialty Solutions Business |
| Paul A. Smith | Senior Vice President of Taxes |
| Kevin W. Emerson | Senior Vice President of Finance Operations |
| Nimesh Jhaveri | Executive Vice President and Chief Impact Officer |
| Stanton McComb | President of Medical-Surgical |
| Kevin Kettler | President of Prescription Technology Solutions and McKesson International |
| Joan Eliasek | President of McKesson Canada |
| Crystal Lennartz M.B.A., Pharm.D. | President of Health Mart |
| Saralisa C. Brau | Corporate Secretary |
| Martin M. Koffel | Executive Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 20, 2025 | ARS | Filing |
| Jun 20, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 20, 2025 | DEF 14A | Other definitive proxy statements |
| Jun 9, 2025 | 8-K | Current Report |
| Jun 6, 2025 | 144 | Filing |
| May 30, 2025 | 144 | Filing |
| May 30, 2025 | 8-K | Current Report |
| May 30, 2025 | SD | Form - SD |
| May 28, 2025 | 144 | Filing |
| May 28, 2025 | 144 | Filing |